SUUS:LSE:LSE-iShares Sustainable MSCI USA SRI UCITS (GBX)

ETF | Others |

Last Closing

USD 1182.75

Change

+0.50 (+0.04)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+170.50 (+0.87%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.31 (+0.91%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.02 (+0.11%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.09%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

+2.35 (+2.01%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.45 (+0.65%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.02 (-0.07%)

USD 260.39B
0QZO:LSE 0QZO

-0.90 (-0.90%)

USD 258.54B

ETFs Containing SUUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.46% 11% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.46% 11% F 20% F
Trailing 12 Months  
Capital Gain 0.11% 30% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.11% 26% F 38% F
Trailing 5 Years  
Capital Gain 115.44% 76% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.44% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.61% 77% C+ 77% C+
Dividend Return 14.61% 76% C+ 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.14% 63% D 79% B-
Risk Adjusted Return 131.17% 98% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike